IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat ® Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available ...
Earlier this week, Masimo announced the FDA clearance of the MightySat Fingertip Pulse Oximeter, representing the first FDA-cleared fingertip pulse oximeter for over-the-counter (OTC) sale directly to ...
IRVINE, Calif. - Masimo (NASDAQ:MASI) has announced the FDA clearance of its MightySat Medical, marking it as the first and only FDA-cleared medical fingertip pulse oximeter available over-the-counter ...
Irvine, CA-based Masimo Corporation (NASDAQ:MASI) announced full market release of the Root monitoring platform with a Kite trademark (a supplementary display system). Root is a patient monitoring and ...
Masimo Corporation MASI announced that it developed three additional indices (delta cHb, delta HHb, and delta O2Hb) for O3 Regional Oximetry. These additions will enable clinicians to view the ...
Joe Kiani, Founder and CEO of Masimo, said, “Until now, consumers and even healthcare providers had no way of knowing what pulse oximeter they could trust to use at home. On the internet and even in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback